Table 1.
Combined Patient Population Characteristics – Second or subsequent complete clinical remission (n = 154)
| Protocol | U (untreated) | G (imatininb) | A (androgen) | V (vaccine) | p |
|---|---|---|---|---|---|
| No. patients 2nd CR or greater | 33 | 30 | 27 | 64 | |
| Stage | 0.17 | ||||
| Stage 1,2 | 3 (9) | 2 (7) | 1 (4) | 12 (19) | |
| Stage 3,4 | 30 (91) | 28 (93) | 26 (96) | 52 (81) | |
| Histology | 0.55 | ||||
| serous | 25 (76) | 21 (70) | 23 (85) | 41 (64) | |
| endometrioid | 6 (18) | 8 (27) | 3 (11) | 18 (28) | |
| other | 2 (6) | 1 (3) | 1 (4) | 5 (8) | |
| Grade | 0.63 | ||||
| 1 | 0/30 (0) | 1 (3) | 2 (7) | 2/61 (3) | |
| 2 | 10/30 (33) | 6 (20) | 9 (33) | 16/61 (26) | |
| 3 | 20/30 (67) | 23 (77) | 16 (59) | 43/61 (70) | |
| Optimal debulking at diagnosis | 0.47 | ||||
| Yes | 15/24 (62) | 22 (73) | 20 (74) | 49/62 (79) | |
| No | 9/24 (37) | 8 (27) | 7 (26) | 13/62 (21) | |
| Surgery at recurrence | 0.001 | ||||
| Yes | 2/33 (6) | 16 (53) | 11 (41) | 16 (25) | |
| No | 31/33 (94) | 14 (47) | 16 (59) | 48 (75) |